Department of Radiation Oncology

Peter E. Gabriel

faculty photo

Peter E. Gabriel, M.D., M.S.E.

Associate Professor of Clinical Radiation Oncology
Department: Radiation Oncology

Contact information
Abramson Cancer Center
Perelman Center for Advanced Medicine
3400 Civic Center Blvd, South Tower 12-106
Philadelphia, PA 19104
Office: 215-615-3437
Education:
A.B. (Computer Science)
Duke University, 1999.
M.D. (Medicine)
Washington University in St. Louis, 2003.
M.S.E. (Technology Management)
University of Pennsylvania School of Engineering & Applied Science / The Wharton School, 2012.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Other Expertise

Dr. Gabriel is Assistant Professor of Clinical Radiation Oncology and Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. He is the Chief Oncology Informatics Officer (COIO) for the Penn Medicine Abramson Cancer Center (ACC) and Director of Informatics for the Department of Radiation Oncology. He has a technical background in computer science and engineering, clinical training in internal medicine, and subspecialty board certification in clinical informatics. As COIO for the ACC, he is responsible for developing and applying innovative approaches to technical infrastructure, workflows, and services that maximize the effective use of clinical information for quality improvement and clinical and translational research in cancer care. His primary areas of interest in informatics include data mining from clinical information systems, electronic phenotyping, database design and clinical data warehouse development, and ontologies and standardized terminologies. Nationally, he is a member of the American Society for Clinical Oncology's Health Information Technology Workgroup and the Epic Oncology Steering Board. He helped to lead the pilot project to develop a national radiation oncology registry.

Selected Publications

Guttmann DM, Gabriel P, Kennedy C, Rate W, Grizos W, Nagda S, Wojtowicz L, Lin L, Freedman GM: Comparison of acute toxicities between contemporary forward-planned 3D conformal radiotherapy and inverse-planned intensity-modulated radiotherapy for whole breast radiation. Breast J 24(2): 128-132, Jul 2018.

Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, Michalski J, Feng M, Marks LB, Fuller CD, Yorke E, Palta J, Gabriel PE, Molineu A, Matuszak MM, Covington E, Masi K, Richardson SL, Ritter T, Morgas T, Flampouri S, Santanam L, Moore JA, Purdie TG, Miller RC, Hurkmans C, Adams J, Jackie Wu QR, Fox CJ, Siochi RA, Brown NL, Verbakel W, Archambault Y, Chmura SJ, Dekker AL, Eagle DG, Fitzgerald TJ, Hong T, Kapoor R, Lansing B, Jolly S, Napolitano ME, Percy J, Rose MS, Siddiqui S, Schadt C, Simon WE, Straube WL, St James ST, Ulin K, Yom SS, Yock TI: American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology. Int J Radiat Oncol Biol Phys 100(4): 1057-1066, Mar 2018.

Remick JS, Schonewolf C, Gabriel P, Doucette A, Levin WP, Kucharczuk JC, Singhal S, Pechet TTV, Rengan R, Simone CB, Berman AT: First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer. Clin Lung Cancer 18(4): 364-371, Jul 2017.

Bagley SJ, Kothari S, Aggarwal C, Bauml JM, Alley EW, Evans TL, Kosteva JA, Ciunci CA, Gabriel PE, Thompson JC, Stonehouse-Lee S, Sherry VE, Gilbert E, Eaby-Sandy B, Mutale F, DiLullo G, Cohen RB, Vachani A, Langer CJ: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung Cancer 106: 1-7, Apr 2017.

Chao HH, Berman AT, Simone CB, Ciunci C, Gabriel P, Lin H, Both S, Langer C, Lelionis K, Rengan R, Hahn SM, Prabhu K, Fagundes M, Hartsell W, Mick R, Plastaras JP.: Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. J Thorac Oncol 12(2): 281-292, Feb 2017.

Christodouleas JP, Hall MD, van der Pas MA, Guo W, Schultheiss TE, Gabriel P: The use of dose-escalated radiation for locally advanced non-small cell lung cancer in the U.S., 2004-2013. Radiat Oncol 12(1): 19, Jan 2017.

Woodhouse KD, Hwang WT, Vapiwala N, Jain A, Wang X, Both S, Shah M, Frazier M, Gabriel P, Christodouleas JP, Tochner Z, Deville C: Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center. Adv Radiat Oncol 2(2): 132-139, Jan 2017.

Gabriel PE, Woodhouse KD, Lin A, Finlay JC, Young RB, Volz E, Hahn SM, Metz JM, Maity A: An automated electronic system for managing radiation treatment plan peer review reduces missed reviews at a large, high-volume academic center. Pract Radiat Oncol 6(6): e307-e314, Nov-Dec 2016.

Ajayi A, Hwang WT, Vapiwala N, Rosen M, Chapman CH, Both S, Shah M, Wang X, Agawu A, Gabriel P, Christodouleas J, Tochner Z, Deville C: Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy. Adv Radiat Oncol 1(4): 325-332, Oct-Dec 2016.

Benedict SH, Hoffman K, Martel MK, Abernethy AP, Asher AL, Capala J, Chen RC, Chera B, Couch J, Deye J, Efstathiou JA, Ford E, Fraass BA, Gabriel PE, Huser V, Kavanagh BD, Khuntia D, Marks LB, Mayo C, McNutt T, Miller RS, Moore KL, Prior F, Roelofs E, Rosenstein BS, Sloan J, Theriault A, Vikram B: Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data. Int J Radiat Oncol Biol Phys 95(3): 873-9, Jul 2016.

back to top
Last updated: 06/05/2018
The Trustees of the University of Pennsylvania
 
Top

© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.